vemurafenib
Showing 26 - 50 of 94
Colorectal Cancer Metastatic Trial in Guangzhou (Cetuximab, Irinotecan, Vemurafenib)
Recruiting
- Colorectal Cancer Metastatic
- Cetuximab
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 7, 2021
Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +5 more
- Atezolizumab
- +3 more
-
Jacksonville, Florida
- +2 more
Oct 21, 2022
Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)
Recruiting
- Advanced Cancer
- Solid Tumor
- Alectinib
- +13 more
-
Helsinki, Uusimaa, Finland
- +2 more
Jun 8, 2022
Melanoma Trial in Worldwide (Atezolizumab, Atezolizumab Placebo, Cobimetinib)
Malignant Melanoma Trial in France, Germany (Vemurafenib, Cobimetinib, Atezolizumab)
Terminated
- Malignant Melanoma
- Vemurafenib
- +2 more
-
Marseille, France
- +6 more
Jan 29, 2021
Advanced Malignant Tumor, BRAF Gene Mutation, Metastatic Malignant Tumor Trial in Houston (Crizotinib, Laboratory Biomarker
Completed
- Advanced Malignant Neoplasm
- +4 more
- Crizotinib
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2021
Melanoma Trial in New York (Vemurafenib)
Terminated
- Melanoma
- Vemurafenib
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Sep 8, 2020
Advanced Cancers Trial in Houston (Vemurafenib, Carboplatin, Paclitaxel)
Completed
- Advanced Cancers
- Vemurafenib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 18, 2020
Cancer, Advanced Solid Tumors Trial in Amsterdam (Sunitinib, Sorafenib, Erlotinib)
Completed
- Cancer
- Advanced Solid Tumors
- Sunitinib
- +9 more
-
Amsterdam, NetherlandsVUMedical Center
Apr 14, 2021
Advanced Cancer, Solid Tumor Trial in Houston (Vemurafenib, Everolimus, Temsirolimus)
Completed
- Advanced Cancer
- Solid Tumor
- Vemurafenib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 1, 2020
Metastatic Melanoma Trial in Copenhagen (Vemurafenib, Lymphodepleting chemo, TIL infusion)
Completed
- Metastatic Melanoma
- Vemurafenib
- +3 more
-
Copenhagen, Herlev, DenmarkCenter for Cancer Immune Therapy, Dept. of Haematology/Oncology
Mar 10, 2020
V600-mutated BRAF Unresectable Melanoma, V600-mutated BRAF Metastatic Melanoma, Stage III or Stage IV Metastatic Melanoma That
Terminated
- V600-mutated BRAF Unresectable Melanoma
- +2 more
- PLX3397
- vemurafenib
-
Los Angeles, California
- +5 more
May 12, 2020
Langerhans Cell Histiocytosis Trial in Moscow (Vemurafenib, Cytarabine, 2-chlorodeoxyadenosine)
Unknown status
- Langerhans Cell Histiocytosis
- Vemurafenib
- +2 more
-
Moscow, Russian FederationDmitry Rogachev National Research Center of Pediatric Hematology
Apr 6, 2020
Metastatic Cancer, Melanoma Trial run by the NCI (Vemurafenib, Young TIL, Cyclophosphamide)
Terminated
- Metastatic Cancer
- Melanoma
- Vemurafenib
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 20, 2019
Metastatic Melanoma, BRAF V600 Mutation Positive Trial in Worldwide (Itraconazole, Rifampin, Vemurafenib)
Completed
- Metastatic Melanoma, BRAF V600 Mutation Positive
- Itraconazole
- +2 more
-
Dallas, Texas
- +10 more
Feb 11, 2020
Relapsed Pediatric Solid Tumor, Refractory Pediatric Solid Tumor, Relapsed Pediatric AML Trial in Seoul (CancerSCAN™,
Recruiting
- Relapsed Pediatric Solid Tumor
- +3 more
- CancerSCAN™
- +17 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 18, 2020